Statistical assessment of the association between vaccination and rare adverse events post-licensure.

Once a new vaccine has been licensed and is in widespread use, it is important to be able to detect and investigate adverse events which may be associated with the vaccine. This is particularly important for rare events which may have been missed in pre-licensure studies. Recent studies investigating adverse events following vaccination have used either a population or a sample of the population (cohort studies), cases matched to controls (case-control studies), or just information on the cases themselves (self-controlled case-series studies). In this paper, the three methods are reviewed and compared and examples are given of recent applications. The effects of potential sources of bias are demonstrated using a data set on MMR vaccine and convulsions.

[1]  R. Davis,et al.  The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. , 2000, Bulletin of the World Health Organization.

[2]  S Suissa,et al.  Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. , 2001, The New England journal of medicine.

[3]  B. Schwartz,et al.  Intussusception among infants given an oral rotavirus vaccine. , 2001, The New England journal of medicine.

[4]  C P Farrington,et al.  Case series analysis of adverse reactions to vaccines: a comparative evaluation. , 1996, American journal of epidemiology.

[5]  Jun Li,et al.  Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association , 1999, The Lancet.

[6]  Farrington Cp Relative incidence estimation from case series for vaccine safety evaluation. , 1995 .

[7]  M. Maclure The case-crossover design: a method for studying transient effects on the risk of acute events. , 1991, American journal of epidemiology.

[8]  C P Farrington,et al.  Idiopathic thrombocytopenic purpura and MMR vaccine , 2001, Archives of disease in childhood.

[9]  C. Lucy Park,et al.  Does Influenza Vaccination Exacerbate Asthma? , 1998, Drug safety.

[10]  M Rush,et al.  A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines , 1995, The Lancet.

[11]  P. Smith,et al.  Use of the case-control approach in vaccine evaluation: efficacy and adverse effects. , 1999, Epidemiologic reviews.

[12]  J P Mullooly,et al.  Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team. , 2000, Archives of family medicine.

[13]  John W. Glasser,et al.  Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. , 1997, Pediatrics.

[14]  P. Fine,et al.  Confounding in studies of adverse reactions to vaccines. , 1992, American journal of epidemiology.